Fig. 6

a Tumorsphere assay in sorted CD133+ vs CD133− cells. Average numbers of tumorspheres are depicted. Note nearly 2–3-fold increased ability to form spheres in CD133+ cells. b Chemosensitivity assay to cisplatin in the four cells lines comparing CD133+ vs CD133− cells. No appreciable differences in sensitivity was observed